DGLA now available in commercial quantities

Equated, a Scottish manufacturer of fatty acid compounds, has developed a method to synthetise the omega-6 fatty acid Dihomma-Gamma-Linolenic Acid (DGLA).

DGLA is well documented for its anti-inflammatory actions but, despite its interest, this substance was not easily accessible from natural source and therefore hardly available. Synthetic DGLA produced by Equated will be marketed under the trade-name EQT-101, and is now avaible for research, pharmaceutical and cosmetic industries from gram to kilogram “For anyone interested in the business of smooth healthy skin,” Equateq CEO, Adam Kelliher, said.

Forward to a friend Send this article by mail

Latest news

09/03/2010	Neopac adds child-resistant feature to its polyfoil tube
09/02/2010	“Important investment underway,” Guillaume de Demandolx, MWV
09/01/2010	A new owner for Alpha Packaging
08/31/2010	Beyond Beauty Paris builds on conferences
08/31/2010	Hair care market growth to remain intact in China
08/31/2010	Pumpart launches a brand new 10 ml airless tube with the technical backup of the Sothys (...)
08/30/2010	L’Air du Temps by Starck: a technical challenge
08/30/2010	Shiseido to celebrate three decades in France
08/30/2010	“We want Brazil to be our second market,” Anna Chaia, (L’Occitane (...)
08/29/2010	Mass retailers test e-mirrors to boost colour cosmetic sales

FOCUS

MakeUp in Paris fulfils its target

Strong attendance and enthusiastic exhibitors: the outcome of the first edition of MakeUp in Paris is more than positive for its organisers. Strong attendance of cosmetic brands As far as attendance is concerned, MakeUp in Paris scored beyond its organizers’ expectations: 1404 visitors thave walked down the aisles of the (...)